Skip to content

Study on improvement of piles symptoms with homoeopathic treatment in frequent travellers

EFFICACY OF HOMOEOPATHIC MEDICINES IN THE MANAGEMENT OF HAEMORRHOIDS IN FREQUENT TRAVELLERS AN EXPERIMENTAL UNCONTROLLED STUDY - Nil

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2026/04/107290
Enrollment
30
Registered
2026-04-01
Start date
Unknown
Completion date
Unknown
Last updated
2026-04-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K64- Hemorrhoids and perianal venous thrombosis

Interventions

Intervention1: Individualized Homoepathic treatment: Individualized homoeopathic medicines will be prescribed based on the totality of symptoms after detailed case-taking and repertorization using hom

Sponsors

Dr Mariya Javeriya Syed Atique Shah
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.Patients diagnosed with haemorrhoids presenting with symptoms such as: Rectal bleeding Anal pain or discomfort Itching (pruritus) Swelling or lump around the anus 2.Patients willing to participate in the study and provide written informed consent 3.Frequent travellers

Exclusion criteria

Exclusion criteria: 1.Patients with 3rd and 4th degree haemorrhoids 2.Patients with other anorectal conditions such as: Fissure in ano Rectal prolapse Ano-rectal malignancy 3.Patients with inflammatory bowel disease (IBD) or haemorrhoids associated with ulcerative colitis 4.Immunocompromised patients or those with severe systemic illnesses (e.g., endocrine disorders, malignancy, chronic debilitating diseases) 5.Patients currently on long-term medication that may affect study outcomes 6.Pregnant women 7.Patients with severe complications of haemorrhoids or other conditions that may interfere with assessment

Design outcomes

Primary

MeasureTime frame
1.To determine Efficacy of Homoeopathic medicines in the management of Haemorrhoids in frequent travellers 2.Reduction in haemorrhoidal symptom severity scoreTimepoint: Outcome assessment will be done at baseline and at monthly follow-ups (1 month, 2 months, and 3 months), with final assessment at 3 months

Secondary

MeasureTime frame
1.Conceptual understanding 2.Clinical assessment 3.Literature review 4.Adverse drug reactionTimepoint: For ADR throughout study period

Countries

India

Contacts

Public ContactDr GS Pangarkar

Sonajirao Kshirsagar Homeopathic Medical College Beed

drganeshspangarkar@gmail.com9422396870

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: May 1, 2026